VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

Ocugen Executive Compensation (FY25)

OCGN · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Shankar Musunuri
Median of the other named officers
$1,192,089
5 officers, excluding the chief executive
Latest say-on-pay support
=
June 11, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on Ocugen

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
10 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Ocugen brief$500Get the executive brief
Velarion Intel, one year, every company
216 figures on this page: 208 cited to the filing that reported them, 8 calculated from figures it prints. See the citations

More on Ocugen

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Shankar Musunuri: $1,941,539 → $4,841,822 (149.4% higher)
Say-on-pay support: 82.2% → 79.0% (3.2 points lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Ocugen's chief executive and what were they paid?
Shankar Musunuri, Chief Executive Officer, Chairman and Co-Founder, received $4,841,822 in total compensation for fiscal 2025. Musunuri's total was 149.4% higher than the $1,941,539 reported for fiscal 2024.
What was Ocugen's say-on-pay result?
Shareholders supported the say-on-pay proposal with 79.0% of votes cast for or against in favor at the meeting held June 11, 2026 for fiscal 2025.
What is Ocugen's chief executive pay ratio?
The company reported a chief executive pay ratio of 2:1 for fiscal 2025.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Shankar Musunuri
Chief Executive Officer
◇◇◇◇——◇◇
Jessica Crespo
Former Chief Accounting Officer and principal accounting officer
◇◇◇◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Shankar Musunuri
Chief Executive Officer
◇◇◇◇——◇◇
Arun Upadhyay
Chief Scientific Officer
◇◇◇◇——◇◇
Quan Vu
Former Chief Financial Officer and Chief Business Officer
Departed during or after this year
◇◇◇◇——◇◇
Jessica Crespo
Former Chief Accounting Officer and principal accounting officer
Departed during or after this year
◇——◇——◇◇
Michael LSSBB
Corporate Controller, Interim Chief Accounting Officer
Served on an interim basis
——————◇◇
Michael Breininger
Corporate Controller, Interim Chief Accounting Officer
Served on an interim basis
——————◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Shankar Musunuri
Chief Executive Officer, Chairman and Co-Founder
◇◇◇◇——◇◇
Huma Qamar
Chief Medical Officer
◇◇◇◇———◇
Huma CMI
Chief Medical Officer
◇◇◇◇———◇
Arun Upadhyay
Chief Scientific Officer
◇◇◇◇——◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Shankar Musunuri
Chief Executive Officer, Chairman and Co-Founder
◇◇◇◇——◇◇
Huma CMI
Chief Medical Officer
◇◇◇◇——◇◇
Huma Qamar
Chief Medical Officer
◇◇◇◇——◇◇
Arun Upadhyay
Chief Scientific Officer
◇◇◇◇——◇— not reconciled
Ramesh CMA
Chief Accounting Officer
◇◇◇◇——◇◇
Ramesh Ramachandran
Chief Accounting Officer
◇◇◇◇——◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Arun UpadhyayOPTION◇——◇—◇◇
Huma Qamar MPH CMIOPTION◇——◇—◇◇
Ramesh Ramachandran CMAOPTION◇——◇—◇◇
Shankar MusunuriOPTION◇——◇—◇◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Huma CMIOption◇—◇April 16, 2034
Option◇—◇January 2, 2035
RSU◇◇——
RSU◇◇——
Option◇—◇January 2, 2035
Shankar MusunuriOption◇—◇January 2, 2035
RSU◇◇——
Option◇—◇January 3, 2033
RSU◇◇——
Option◇—◇January 2, 2034
Option◇—◇January 2, 2035
RSU◇=——
Arun UpadhyayRSU◇◇——
Option◇—◇January 2, 2035
Option◇—◇January 2, 2035
Option◇—◇January 3, 2033
RSU◇◇——
RSU◇◇——
Option◇—◇January 2, 2034
Ramesh RamachandranRSU◇◇——
Option◇—◇January 2, 2035
Option◇—◇January 2, 2035
Option◇—◇September 16, 2034
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Uday B. Kompella, Ph.D
◇—◇———◇
Satish Chandran, Ph.D
◇—◇——◇◇
Kirsten Castillo, MBA
◇—◇———◇
Junge Zhang, Ph.D
◇—◇———◇
Blaise Coleman, MBA
◇—◇———◇
Prabhavathi Fernandes, Ph.D., FIDSA
◇—————◇
Marna C. Whittington, Ph.D
◇—————◇
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as Options.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 11, 2026=◇◇◇
2024June 5, 2025=◇◇◇
2023June 28, 2024=◇◇◇
2022June 23, 2023=◇◇◇
2021June 7, 2022=◇◇◇
2020July 2, 2021=◇◇◇
2019December 23, 2020=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Shankar Musunuri (Chief Executive Officer, Chairman and Co-Founder), FY2025 total compensation $4,841,822 (base salary $757,900) [exec_comp, SEC accession 0001140361-26-017260, filed 2026-04-28]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Tell me when Ocugen files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Ocugen disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Ocugen's disclosed peer group is defensible, who names Ocugen back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
216 figures on this page: 208 cited to the filing that reported them, 8 calculated from figures it prints.
208 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001104659-26-073015
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001140361-26-017260
    2025 EXECUTIVE COMPENSATION TABLES · DIRECTOR COMPENSATION PROGRAM
  3. 0001104659-25-056875
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001140361-25-015803
    2024 EXECUTIVE COMPENSATION TABLES
  5. 0001104659-24-076278
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001104659-24-065576
    2023 EXECUTIVE COMPENSATION TABLES
  7. 0001104659-23-074970
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001104659-22-068955
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001104659-21-088830
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001104659-20-139852
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Ocugen executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/OCGN (accessed 2026).
Short form: data: Velarion

The paid brief for Ocugen

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Ocugen and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}